In the MC38-Ova tumor model, Ptpn13 knockout enhanced OVA antigen presentation on MC38-Ova-shApc cells and increased the frequency of antigen-specific CD8+ T cells, indicating improved antigen-specific CD8+ T cell responses (Fig. 4d, e). Here, PTPN13 is linked to neoplasm.